Effects of PPAR-γ agonists on oral cancer cell lines: Potential horizons for chemopreventives and adjunctive therapies.
Jeffrey A HallMark RustenRaed D AbughazalehBeverly R WuertzVannesa SouksavongPaul J EscherFrank G OndreyPublished in: Head & neck (2020)
Our results suggest these agents, in addition to activating PPAR-γ, can downregulate NF-κB and potentiate apoptosis in oral cancer cells.